Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
Pisani
F
F
Clinica Chirurgica, Università Tor Vergata, Rome, Italy.
Tisone
G
G
Alciati
E
E
Vennarecci
G
G
Pieragostini
E
E
Casciani
C U
CU
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006400:Hematocrit; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011086:Polycythemia / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications / Q000188:drug therapy; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D013256:Steroids; D004656:Enalapril; D016572:Cyclosporine; D002216:Captopril; D001379:Azathioprine